A Study of Brepocitinib in Adults With Active Non-Infectious Non-Anterior Uveitis
Public ClinicalTrials.gov record NCT05523765. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2 Randomized, Double-Masked, Dose-Ranging Study to Investigate the Safety and Efficacy of Oral Brepocitinib in Adults With Active Non-Infectious Intermediate-, Posterior-, and Panuveitis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study will evaluate the clinical safety and efficacy of oral brepocitinib in participants with active intermediate, posterior, or pan non-infectious uveitis (NIU).
Study identification
- NCT ID
- NCT05523765
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 26 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 74 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 14, 2022 (Actual)
- Primary completion
- Jul 30, 2024 (Actual)
- Completion
- Jul 30, 2024 (Actual)
- Last update posted
- Jul 25, 2025
2022 – 2024
United States locations
- U.S. sites
- 15
- U.S. states
- 10
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Clinical Trial Site | Los Angeles | California | 90095 | — |
| Clinical Trial Site | Palo Alto | California | 94303 | — |
| Clinical Trial Site | Pasadena | California | 91107 | — |
| Clinical Trial Site | Lakewood | Colorado | 80228 | — |
| Clinical Trial Site | Waltham | Massachusetts | 02451 | — |
| Clinical Trial Site | St Louis | Missouri | 63110 | — |
| Clinical Trial Site | Palisades Park | New Jersey | 07650 | — |
| Clinical Trial Site | Durham | North Carolina | 27710 | — |
| Clinical Trial Site | Winston-Salem | North Carolina | 27157 | — |
| Clinical Trial Site | Eugene | Oregon | 97401 | — |
| Clinical Trial Site | Nashville | Tennessee | 37203 | — |
| Clinical Trial Site | Bellaire | Texas | 77401 | — |
| Clinical Trial Site | Katy | Texas | 77494 | — |
| Clinical Trial Site | Plano | Texas | 75075 | — |
| Clinical Trial Site | Salt Lake City | Utah | 84107 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05523765, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 25, 2025 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT05523765 live on ClinicalTrials.gov.